Licensing

The DIDB® and e-PKGene® applications which are part of UW Drug Interaction Solutions are available for licensing. The current license allows access to the applications for one year and includes individual or group training, updates of information, and Database enhancements. Licensing and pricing information is available from UW CoMotion’s Express Licensing Program. Alternate access and licenses may be discussed by contacting UW CoMotion.

Conditions of Use

The intended audience of the online DIDB® and e-PKGene® applications is composed of individuals knowledgeable in drug interactions, and use is governed by the Agreement accepted by the User /User’s organization. By accessing and using the DIDB® and e-PKGene® applications, User acknowledges that the User has been made aware of the disclaimers in the Agreement, specifically including those disclaimers which state that the Database is solely a selected compilation of publicly available literature, and that the University of Washington makes no warranty on the accuracy, validity, completeness or availability of information cited in the DIDB® and e-PKGene® applications. The information contained in the DIDB® and e-PKGene® applications is intended as a supplement to, and not as a substitute for, the knowledge, expertise, skill and judgment of Authorized Users. The absence of warning for a given drug or drug combination should not be construed to indicate that the drug or drug combination is safe, appropriate or effective in any given patient.

More Information

If you need more information about the UW PK-based Drug Interaction Knowledgebase, please contact us.